Page last updated on September 20, 2024
INTEGRATED BIOPHARMA INC reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-09-20 16:45:05 EDT.
Filings
10-K filed on 2024-09-20
INTEGRATED BIOPHARMA INC filed a 10-K at 2024-09-20 16:45:05 EDT
Accession Number: 0001437749-24-029768
Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!
Item 1C. Cybersecurity.
Item 1C. Cybersecurity Managing technology risks, including cybersecurity risks, is a fundamental part of the Company’s risk management framework and processes. We employ a variety of processes, risk assessments, and controls to assess, identify, and manage these risks and have developed and maintain a cyber risk management program designed to identify, assess, manage, mitigate and respond to cybersecurity threats. The program is one component of our enterprise risk management system. The technical, administrative and physical controls underlying our program are based on nationally recognized practices and standards for cybersecurity. Trusted partners are an important part of our cyber risk management program. We partner with service providers to conduct periodic risk assessments and to monitor and maintain the performance and effectiveness of security controls used in our environment. -14- The Audit Committee of the Board of Directors (the “Audit Committee”) oversees our management of enterprise risks, including cybersecurity risks. Members of the management team brief the Board of Directors and Audit Committee on the effectiveness of risk management efforts on an annual basis. Our cyber risk management program helps mitigate risks that could have a material adverse effect on our business, financial condition, results of operations, cash flows or reputation. Security breaches and other disruptions could compromise our information and expose us to liability, and could cause our business and reputation to suffer. As of the date of this Annual Report on Form 10-K we are not aware of any cybersecurity incidents that have materially affected or are reasonably likely to materially affect our business, results of operations or financial condition. However, despite our best efforts, we cannot eliminate all risks from cybersecurity threats or provide assurances that we have not experienced undetected cybersecurity incidents. See “Risk Factors” in Item 1A in this Annual Report on Form 10-K for further discussion.
Company Information
Name | INTEGRATED BIOPHARMA INC |
CIK | 0001016504 |
SIC Description | Pharmaceutical Preparations |
Ticker | INBP - OTC |
Website | |
Category | Non-accelerated filer Smaller reporting company |
Fiscal Year End | June 29 |